2025-08-15 TICC - 3F South Lounge
時間主題
13:40 ~ 13:44
#240 Gleason Score Upgrading in Grade Group 1 Prostate Cancer: Insights from a Retrospective Cohort Study
講者: Chi-Chun Hsieh 座長: Prof. Masaki Shiota,
Sheng-Tang Wu
13:48 ~ 13:52
#404 Establishment of Two Cases of PDX from Organoids Derived from CTCs Collected from Prostate Cancer Patient's blood
講者: Kensuke Hikami 座長: Prof. Masaki Shiota,
Sheng-Tang Wu
13:52 ~ 13:56
#423 Cell-free DNA analysis for precision medicine in metastatic castration-sensitive prostate cancer
講者: Maki Fujiwara 座長: Prof. Masaki Shiota,
Sheng-Tang Wu
13:56 ~ 14:00
#444 Management of Cardiometabolic Risk in Prostate Cancer: Expert Consensus from Singapore and Malaysia
講者: Jeffrey Tuan 座長: Prof. Masaki Shiota,
Sheng-Tang Wu
14:00 ~ 14:04
#91 Assessing the Outcomes of Focal Therapy as the Primary Treatment of Prostate Cancer In Asian Populations: A Comprehensive Systematic Review and Meta-analysis
講者: XinYan Yang 座長: Prof. Masaki Shiota,
Sheng-Tang Wu
14:04 ~ 14:08
#588 Neuregulin-1 Regulation of Cell Proliferation and Survival in Castration-Resistant Prostate Cancer: Implications for Cellular Senescence
講者: Shao-Lun Hung 座長: Prof. Masaki Shiota,
Sheng-Tang Wu
14:08 ~ 14:12
#611 Assessing Biochemical Recurrence After Prostatectomy in Prostate Cancer Patients Using F-18-PSMA-1007 PET: Insights from Our Institute
講者: Yu-Kai Huang 座長: Prof. Masaki Shiota,
Sheng-Tang Wu
14:12 ~ 14:16
#612 Assessing Outcome of Radiotherapy with Concurrent Androgen Deprivation Therapy in Biochemical Recurrence After Prostatectomy Patients Using F-18-PSMA-1007 PET
講者: Yu-Kai Huang 座長: Prof. Masaki Shiota,
Sheng-Tang Wu
14:16 ~ 14:20
#616 Deep response of Apalutamide in high risk mCSPC, CGRD experience
講者: Yu-An LIN 座長: Prof. Masaki Shiota,
Sheng-Tang Wu
14:20 ~ 14:24
#673 Algorithmic Prediction of Gleason Score Upgrading in Biopsy 3+3 Prostate Cancer: Insights from a Retrospective Cohort
講者: Tai-Hua Chiu 座長: Prof. Masaki Shiota,
Sheng-Tang Wu
14:24 ~ 14:28
#691 Boosting Survival with Cytoreductive Radical Prostatectomy in Metastatic Hormone-Sensitive Prostate Cancer: Insights from a Retrospective Analysis
講者: Yi Hong Li 座長: Prof. Masaki Shiota,
Sheng-Tang Wu
14:28 ~ 14:32
#745 A Multicenter Analysis of Long-Term Oncological Outcomes Comparing EBRT and HIFU for Prostate Cancer Using IPTW and the Chang Gung Research Database
講者: Hsing-Tsuo Yeh 座長: Prof. Masaki Shiota,
Sheng-Tang Wu
14:32 ~ 14:36
#746 Is bone scan necessary of low/very low prostate cancer patients? A retrospective study in Taiwan
講者: Meng Hsien Chen 座長: Prof. Masaki Shiota,
Sheng-Tang Wu
14:36 ~ 14:40
#755 CEMIP and CTCF role in castration-resistant prostate cancer: A novel insight from 3D spheroid model
講者: Salida Ali 座長: Prof. Masaki Shiota,
Sheng-Tang Wu
14:40 ~ 14:44
#24 IL-8/CXCR2 Mediate Lipid Accumulation in Prostate Cancer Microenvironment and reshapes the Tumor Immune Microenvironment
講者: Yi Sun 座長: Prof. Masaki Shiota,
Sheng-Tang Wu
14:44 ~ 14:48
#346 Enzalutamide (ENZA)±leuprolide (L) in biochemically recurrent (BCR) prostate cancer (PC): EMBARK post hoc analysis of Asia Pacific (APAC) population
講者: Hsi-Chin Wu 座長: Prof. Masaki Shiota,
Sheng-Tang Wu
14:48 ~ 14:52
#140 Identification of putative prognostic genes associated with neddylation in prostate cancer
講者: Yinglong Huang 座長: Prof. Masaki Shiota,
Sheng-Tang Wu
14:52 ~ 14:56
#141 Single-cell and transcriptomic data integrated mendelian randomization study reveals the potential value of prognostic genes associated with mitochondria and programmed cell death in prostate cancer
講者: Yinglong Huang 座長: Prof. Masaki Shiota,
Sheng-Tang Wu
14:56 ~ 15:00
#532 Single-Cell RNA Sequencing of Prostate Cancer Reveals Epithelial Cells Characterized by Epithelial-Mesenchymal Transition Associated with Disease Progression in Rare Pathological Types
講者: Changxuan Wang 座長: Prof. Masaki Shiota,
Sheng-Tang Wu